Seminars in Oncology
Volume 36, Issue 5 , Pages 451-459 , October 2009

Cancer of the Oral Cavity and Pharynx in Young Females: Increasing Incidence, Role of Human Papilloma Virus, and Lack of Survival Improvement

  • Archie Bleyer

      Affiliations

    • Corresponding Author InformationAddress correspondence to Archie Bleyer, MD, St. Charles Medical Center, 2500 NE Neff Rd, Bend, OR 97701

References 

  1. National Center for Health Statistics. Early release of selected estimates based on data from the January-June 2007 National Health Interview Study (Released 12/10/2007). www.cdc.gov/nchs/about/major/nhis/released200712.htmAccessed May 26, 2008
  2. Schroeder S. Stranded in the periphery—the increasing marginalization of smokers. N Engl J Med. 2008;358:2284–2286
  3. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer. 2007;110:1429–1435
  4. Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008;113(Suppl):2901–2909
  5. Chaturvedi A, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus–related and –unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–619
  6. Gillison ML, Koch WM, Capone RB, Gillison ML, Danish HN, Westra WH, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–720
  7. Gillison ML. Molecular and epidemiologic data associate HPV primarily with cancers that arise in the oropharynx, including the lingual and palatine tonsils and base of tongue (Current topics in the epidemiology of oral cavity and oropharyngeal cancers). Head Neck. 2007;29:779–792
  8. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006;24:2606–2611
  9. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–1956
  10. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001;93:232–235
  11. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125–1131
  12. Hammarstedt L, Lindquist D, Dahlstrand H, Ferrer KT, Nodzenski E, Sabnani JB, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620–2623
  13. Williams H, Higgins CD, Crawford DH. Human papillomavirus and oropharyngeal cancer. [letter] N Engl J Med. 2007;357:1157
  14. McDougall JK. Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol. 1994;186:101–119
  15. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 1998;58:5–13
  16. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene. 2002;21:1510–1517
  17. Hafkamp HC, Speel EJ, Haesevoets A, Voogd AC, Schepers M, Bot FJ, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer. 2003;107:394–400
  18. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER cancer statistics review, 1975-2005. Bethesda, MD: National Cancer Institute http://seer.cancer.gov /csr/1975_2005/based on November 2007 SEER data submission, posted to the SEER web site, 2008. Accessed March 15, 2009
  19. Surveillance, Epidemiology, and End Results (SEER) program (www.seer.cancer.gov) SEER*Stat database: mortality—all COD, aggregated with state, total U.S. (1969-2005) <Katrina/Rita Population Adjustment>, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008. www.seer.cancer.gov/seerstat. Accessed March 15, 2009.
  20. American Cancer Society. Cancer facts & figures 2008. Atlanta: American Cancer Society; 2008;
  21. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263–1269
  22. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104:336–344
  23. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772–1783
  24. Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;l96:449–455
  25. Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004;108:766–772
  26. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczyncki SP, et al. Human papillomavirus (HPV) in head and neck cancer (An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring). Cancer. 1997;79:595–604
  27. Fouret P, Monceaux G, Temam S, Lacourreye L, St Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg. 1997;123:513–516
  28. Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag AGraves D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res. 1996;2:755–762
  29. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res. 2002;8:3187–3192
  30. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg. 1989;115:621–625
  31. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998;90:1626–1636
  32. Jayant K, Deo MG. Oral cancer and cultural practices in relation to betel quid and tobacco chewing and smoking. Cancer Detect Prev. 1986;9:207–213
  33. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407–420
  34. Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003;162:747–753
  35. Strome SE, Savva A, Brissett AE, Gostout BS, Lewis J, Clayton AC, et al. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res. 2002;8:1093–1100
  36. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805–813
  37. Portugal LG, Goldenberg JD, Wenig BL, Ferrer KT, Nodzenski E, Sabnani JB, et al. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1997;123:1230–1234
  38. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813–1820
  39. Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JM, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008;26(19):3138–3146
  40. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, et al. EGFR, p16, HPV titer, bcl-xl and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3138–3146
  41. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus–positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–269
  42. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288–298
  43. Hampton T. Cancer treatment's trade-off. JAMA. 2005;294:167–168
  44. Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin. 2007;l57:242–255
  45. Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med. 2009;361:271–278
  46. Rintala M, Grénman S, Puranen M, Syrjänen S. Natural history of oral human papillomasvirus infections in female and male partners: a prospective Finnish HPV Family Study. J Clin Virol. 2006;35:89–94
  47. Syrjänen S. Human papillomaviruses in head and neck carcinomas. N Engl J Med. 2007;356:1994–1995
  48. Jacob HS. Adolescent sexual behavior: a plea for HPV vaccination for prepubescent boys (as well as girls). Hematol Oncol Today. 2008;25:4
  49. Assessing the burden of HPV-associated cancers in the United States. 2008;113 Suppl 10:2837-3057.
  50. Baden LR, Curfman GD, Morrissey SM, Drazen JM. Human papillomavirus vaccine—opportunity and challenge. N Engl J Med. 2007;356:1990–1991

 Supported in part by the Aflac Foundation.

PII: S0093-7754(09)00140-7

doi: 10.1053/j.seminoncol.2009.07.005

Seminars in Oncology
Volume 36, Issue 5 , Pages 451-459 , October 2009

Article Tools

* Image Usage & Resolution